TWO SIGMA INVESTMENTS, LP - NEUBASE THERAPEUTICS INC ownership

NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 53 filers reported holding NEUBASE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of NEUBASE THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$19,000
-93.9%
10,222
-88.1%
0.00%
-100.0%
Q3 2021$310,000
-65.0%
85,796
-53.6%
0.00%
-50.0%
Q2 2021$886,000
+29.9%
184,931
+100.3%
0.00%0.0%
Q1 2021$682,000
+582.0%
92,324
+707.8%
0.00%
Q2 2020$100,00011,4290.00%
Other shareholders
NEUBASE THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Greenlight Capital 2,027,027$15,386,0001.26%
Sio Capital Management, LLC 304,376$2,310,0000.46%
GSA CAPITAL PARTNERS LLP 96,586$733,0000.12%
SPHERA FUNDS MANAGEMENT LTD. 150,000$1,139,0000.11%
Frontier Wealth Management LLC 145,000$1,101,0000.10%
Oak Grove Capital LLC 19,975$152,0000.07%
FNY Investment Advisers, LLC 15,000$113,0000.05%
PREMIER ASSET MANAGEMENT LLC 12,977$98,0000.02%
PILLAR PACIFIC CAPITAL MANAGEMENT LLC 19,800$150,0000.01%
Heritage Wealth Advisors 11,000$83,490,0000.01%
View complete list of NEUBASE THERAPEUTICS INC shareholders